Nao Suzuki
Department of Obstetrics and Gynecology
School of Medicine
Keio University
Tokyo
Japan
Name/email consistency: high
- A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma. Suzuki, N., Aoki, D., Oie, S., Horiuchi, M., Hasegawa, Y., Ezawa, S., Suzuki, A., Susumu, N., Hosoi, F., Kitazato, K., Nozawa, S. Gynecol. Oncol. (2004)
- HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells. Suzuki, N., Aoki, D., Tamada, Y., Susumu, N., Orikawa, K., Tsukazaki, K., Sakayori, M., Suzuki, A., Fukuchi, T., Mukai, M., Kojima-Aikawa, K., Ishida, I., Nozawa, S. Gynecol. Oncol. (2004)